The healthcare mergers and acquisitions (M&A) market remained active in Q2 2025, with several sectors including physician practice management (PPM), clinical research, and digital health experiencing continued investment and...more
7/30/2025
/ Acquisitions ,
Ambulatory Surgery Centers ,
Digital Health ,
EBITDA ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Healthcare Reform ,
Home Health Care ,
Hospice ,
Hospitals ,
Managed Care Contracts ,
Medical Research ,
Medicare Advantage ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Physicians ,
Popular ,
Private Equity ,
Technology Sector ,
Value-Based Care
The healthcare mergers and acquisitions (M&A) market began 2025 with a slower start than expected given the easing headwinds and building momentum at the end of last year, with the number of deals reported in Q1 lower than...more
4/17/2025
/ Acquisitions ,
Ambulatory Surgery Centers ,
Clinical Trials ,
Digital Health ,
Health Information Technologies ,
Health Insurance ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Investors ,
Managed Care Contracts ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Physicians ,
Popular ,
Private Equity ,
Regulatory Requirements ,
Value-Based Care
Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing...more
7/17/2024
/ Ambulatory Surgery Centers ,
Digital Health ,
Health Care Providers ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Investment ,
Investment Partnerships ,
Investors ,
Managed Care Contracts ,
Medical Research ,
Pharmaceutical Industry ,
PHI ,
Popular ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity. As we begin 2024, we have highlighted the issues and trends that...more
1/9/2024
/ Acquisitions ,
Artificial Intelligence ,
Corporate Transparency Act ,
Department of Justice (DOJ) ,
Diversity ,
Equity Markets ,
FinCEN ,
Funding ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Non-Compete Agreements ,
Pharmaceutical Industry ,
Popular ,
Privacy Laws ,
Private Equity ,
Reporting Requirements ,
Restrictive Covenants ,
Risk Management ,
Safe Harbors ,
Section 340B ,
Self-Disclosure Requirements ,
Value-Based Care
2022 started strong for healthcare transactions with some reports suggesting a record-breaking January. Although deal activity cooled in February and March, transaction pipelines still indicate that 2022 is on pace to match...more
4/15/2022
/ Acquisitions ,
Ambulatory Surgery Centers ,
Dental Practice ,
Digital Health ,
Health Information Technologies ,
Home Health Care ,
Hospice ,
Hospitals ,
Investment ,
Investors ,
Life Sciences ,
Managed Service Providers (MSPs) ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Popular ,
Private Equity